Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie A Sullivan

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|March 4, 2021
SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian CancerArthur-Quan Tran, Stephanie A Sullivan, Leo Li-Ying Chan, et al.
Gynecologic Oncology|December 24, 2017
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phaseArthur-Quan Tran, Daniel O Erim, Stephanie A Sullivan, et al.
Archives of Gynecology and Obstetrics|January 29, 2026
Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort studyClaudia A Bale, Janina V Pearce, Xiaoyan Deng, et al.
American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Translational Research|July 19, 2018
Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cellsGuangxu Xu, Ziwei Fang, Leslie H Clark, et al.
World Journal of Clinical Oncology|June 30, 2021
Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancerJordan T Lee, Chad W Wagoner, Stephanie A Sullivan, et al.
Frontiers in Oncology|August 2, 2021
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian CancerGuangxu Xu, Weimin Kong, Ziwei Fang, et al.
American Journal of Cancer Research|September 14, 2018
ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitroZiwei Fang, Jiandong Wang, Leslie H Clark, et al.
American Journal of Obstetrics and Gynecology|February 1, 2015
Obesity and perioperative pulmonary complications in robotic gynecologic surgeryWeiya Z Wysham, Kenneth H Kim, Jared M Roberts, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|March 4, 2021
SPR965, a Dual PI3K/mTOR Inhibitor, as a Targeted Therapy in Ovarian CancerArthur-Quan Tran, Stephanie A Sullivan, Leo Li-Ying Chan, et al.
Gynecologic Oncology|December 24, 2017
Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phaseArthur-Quan Tran, Daniel O Erim, Stephanie A Sullivan, et al.
Archives of Gynecology and Obstetrics|January 29, 2026
Prognostic value of FDG-PET SUV changes in cervical cancer following radiation therapy: a retrospective cohort studyClaudia A Bale, Janina V Pearce, Xiaoyan Deng, et al.
American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Translational Research|July 19, 2018
Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cellsGuangxu Xu, Ziwei Fang, Leslie H Clark, et al.
World Journal of Clinical Oncology|June 30, 2021
Impact of community-based exercise program participation on aerobic capacity in women with and without breast cancerJordan T Lee, Chad W Wagoner, Stephanie A Sullivan, et al.
Frontiers in Oncology|August 2, 2021
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian CancerGuangxu Xu, Weimin Kong, Ziwei Fang, et al.
American Journal of Cancer Research|September 14, 2018
ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitroZiwei Fang, Jiandong Wang, Leslie H Clark, et al.
American Journal of Obstetrics and Gynecology|February 1, 2015
Obesity and perioperative pulmonary complications in robotic gynecologic surgeryWeiya Z Wysham, Kenneth H Kim, Jared M Roberts, et al.
Pageof 4